David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Oxymetazoline 1% Cream for 1H 2017

Oxymetazoline 1% Cream for 1H 2017

Allergan today have confirmed that a new drug application for their 1% oxymetazoline hcl cream has been formally lodged with the FDA. The prediction from Allergan is that the approval will come in the first half of 2017. This is the first confirmation that Allergan has settled on a 1% formulation of oxymetazoline hydrochloride, having […]

Continue Reading

Vanessa’s Rosacea Story

Written by on May 25, 2016 in My Rosacea Story with 0 Comments

Rosacea News is starting a new series of articles that I’m calling “My Rosacea Story”. There is real power in hearing other people’s stories. We’d love to hear from you too. Feel free to send me an email, and to use the following questions as a starting point. Thanks to Vanessa for sharing your Rosacea […]

Continue Reading

RosaceaCare Tinted ZincO Cream User Reviews

RosaceaCare Tinted ZincO Cream User Reviews

ZincO Cream as a product has been around for many years now. It is time that it had its own page on this site where we can collect reviews and comments in one place. I still use ZincO Cream everyday to offer protection from the sun and to smooth over facial redness. I trust that you […]

Continue Reading

Timolol (Timoptic) for the redness of rosacea

Written by on May 23, 2016 in clinical trials, New Rosacea Treatments with 2 Comments
Timolol (Timoptic) for the redness of rosacea

The glaucoma treament Timolol is to be trialed as a treatment for the facial redness of rosacea. Timolol is a non-selective beta-adrenergic receptor antagonist, somewhat similar to Brimonidine. Mirvaso is the recently approved treatment for the red face of rosacea that is based on bromonidine. Timolol has been used in the past as a dermatological agent […]

Continue Reading

Finacea Foam makes $680K for Foamix

Finacea Foam makes $680K for Foamix

A recent press release from Foamix gives a view into how well Finacea Foam is selling. Based on Q1 2016 sales of the newly approved Finacea Foam, Bayer HealthCare made a royalty payment of $682,000 to Foamix as a fee for licensing their foaming technology. Along with the comment that Finacea Foam sales are continuing […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.